Get started
Author

Michael Starke

ORCID: 0009-0001-8753-6347
Observed ORCID: 0009-0001-8753-6347
OpenAlex ID: A5134070024
Immunohistochemical Evaluation of Integrin β6 Expression in Triple-Negative Breast Cancer as a Predictive Biomarker for Therapeutic and Diagnostic Radionuclides
2026 · Muin Tuffaha, Wael Hananeh, et al. · Biomolecules · 3
Immunohistochemical Evaluation of Integrin αvβ6 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma as a Histopathology-Driven Biomarker for Integrin αvβ6-Targeted Radiotheranostics
2026 · Muin Tuffaha, Wael Hananeh, et al. · Cancers · 2
PDF
Integrin αvβ6 Expression in the Human Pituitary Gland and Pituitary Neuroendocrine Tumors: Immunohistochemical Characterization with Potential Relevance to αvβ6 PET/CT Pituitary Uptake and Theranostic Implications
2026 · Muin Tuffaha, Wael Hananeh, et al. · Biomolecules · 1
Potentials and Challenges of Unmanned Aerial Vehicle–Based Transport for the Time-Critical Delivery of Positron Emission Tomography Radiopharmaceuticals in Nuclear Medicine
2026 · Olga Varlamova, Jan Bredow, et al. · Nuklearmedizin - NuclearMedicine
Marinelli Equation vs. DIN 6861-1: Comparison of the Achieved Therapeutic Thyroid Dose after Radioiodine Therapy Using Different Pretherapeutic Dosimetry
2026 · Patrick Heilfort, Olga Varlamova, et al. · Nuklearmedizin - NuclearMedicine
Integrin αvβ6 Expression in Parathyroid Adenomas and Adjacent Non-Neoplastic Parathyroid Tissue: Immunohistochemical Rationale for Integrin αvβ6-Targeted PET Imaging
2026 · Amro Tuffaha, Wael Hananeh, et al. · Cancers
Immunohistochemical Expression of Integrin αvβ6 in Surgically Resected Pulmonary Inflammatory Lesions Mimicking Malignancy on 18F-FDG PET/CT: Implications for the Specificity of 68Ga-Trivehexin PET/CT
2026 · Muin Tuffaha, Amro Tuffaha, et al. · Biomolecules
PDF
Works count: 7
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type